التفاصيل البيبلوغرافية
| العنوان: |
Antibiotic susceptibility of Helicobacter pylori in Iceland. |
| المؤلفون: |
Gunnarsdottir, Anna Ingibjorg, Gudjonsson, Hallgrimur, Hardardottir, Hjordis, Jonsdottir, Karen Drofn, Bjornsson, Einar Stefan |
| المصدر: |
Infectious Diseases; 2017, Vol. 49 Issue 9, p647-654, 8p |
| مصطلحات موضوعية: |
HELICOBACTER disease diagnosis, ANTIBIOTICS, BIOPSY, CHI-squared test, DRUG resistance in microorganisms, GASTROSCOPY, HELICOBACTER diseases, HELICOBACTER pylori, LONGITUDINAL method, METRONIDAZOLE, MICROBIAL sensitivity tests, PROBABILITY theory, QUINOLONE antibacterial agents, RESEARCH funding, SEX distribution, T-test (Statistics), TETRACYCLINE, UREASE, AMPICILLIN, DESCRIPTIVE statistics, CLARITHROMYCIN |
| مصطلحات جغرافية: |
ICELAND |
| مستخلص: |
Background:Increasing resistance ofHelicobacter pylori (H. pylori)to antibiotics calls for constant re-evaluation of multidrug regimens that have been used to eradicate the infection. The aim of this study was to evaluate the current antibiotic susceptibility ofH. pyloriin an Icelandic cohort. Methods:Patients referred for gastroscopy were recruited prospectively. Those found to have a positive rapid urease test were included in the study. Susceptibility testing was conducted by the Epsilometer test (E-test) method for ampicillin, clarithromycin, levofloxacin, metronidazole and tetracycline. Results were obtained after three days of incubation in microaerophilic conditions at 37 °C, except for the metronidazole were the first 24 hours were anaerobic. Results:Of the 613 patients who underwent gastroscopy, 138 (23%) had a positive rapid urease test.H. pyloriwas successfully cultured from 105 (76%) of the urease test positive patients and the isolates were tested for antibiotic susceptibility. Five patients had priorH. pylorieradication. Antibiotic resistance for ampicillin, clarithromycin, levofloxacin, metronidazole and tetracycline was 0%, 9%, 4%, 1% and 0%, respectively. If those who had previously undergone eradication treatment were excluded, the resistance was 0%, 6%, 3%, 1% and 0%, respectively. Clarithromycin resistance was higher amongst women than men, 13% vs. 5%, however, not significantly. Clarithromycin resistance was 60% amongst those who had previously received eradication treatment compared to 6% of those who had not (p < .0001). Conclusions:Clarithromycin resistance amongst theH. pyloriisolates can be considered relatively low. Therefore, in the current cohort, standard triple-drug clarithromycin-containing regimen should remain the first-line treatment againstH. pylori. [ABSTRACT FROM PUBLISHER] |
|
Copyright of Infectious Diseases is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
